Hopes for the Johnson & Johnson (J&J) Mosaico vaccine were dashed when the manufacturer announced that the vaccine lacked efficacy in preventing HIV infection.
Big Pharma company Johnson & Johnson (J&J) has announced that it has discontinued the creation of an HIV vaccine after a large clinical trial found that the experimental treatment was not [.]
The only HIV vaccine currently in late-stage trials, which was developed by J&J, has been discarded after tests showed that it was ineffective against the virus.